We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Crimean-Congo haemorrhagic fever (CCHF) is a viral haemorrhagic fever (VHF) caused by a virus of the Nairovirus group.
When entering the UK, you need to prove your medicine is prescribed to you if it contains a controlled drug - find out what proof you need to get.
FCDO travel advice for Brazil. Includes safety and security, insurance, entry requirements and legal differences.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Guidance for prescribing vets on the use of the cascade.
Advice for medical professionals to follow when assessing drivers with psychiatric disorders.
The management, surveillance and epidemiology of carbapenem resistance.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
How traditional herbal medicines and homeopathic medicines will be treated by the MHRA.
Decisions made by MHRA on adverts reported to have breached the legislation on advertising medicines.
Collection of information and guidance for patients and for healthcare professionals on the reproductive risks of valproate and new safety measures introduced to reduce these risks.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The CMU is part of the Medicine, Pharmacy and Industry Group of DHSC which looks at supply and procurement in hospitals.
Advice and guidance on the health needs of migrant patients from Thailand for healthcare practitioners.
Guidance for pharmacists on prescriptions issued in EU countries, Norway, Iceland, Liechtenstein and Switzerland.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.